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Abstract
When compared to other model organisms whose genome is se-
quenced, the number of mutations identified in the mouse appears
extremely reduced and this situation seriously hampers our under-
standing of mammalian gene function(s). Another important conse-
quence of this shortage is that a majority of human genetic diseases
still await an animal model. To improve the situation, two strategies
are currently used: the first makes use of embryonic stem cells, in
which one can induce knockout mutations almost at will; the second
consists of a genome-wide random chemical mutagenesis, followed
by screening for mutant phenotypes and subsequent identification of
the genetic alteration(s). Several projects are now in progress making
use of one or the other of these strategies. Here, we report an original
effort where we mutagenized BALB/c males, with the mutagen
ethylnitrosourea. Offspring of these males were screened for domi-
nant mutations and a three-generation breeding protocol was set to
recover recessive mutations. Eleven mutations were identified (one
dominant and ten recessives). Three of these mutations are new alleles
(Otop1mlh, Foxn1sepe and probably rodador) at loci where mutations
have already been reported, while 4 are new and original alleles (carc,
eqlb, frqz, and Sacc). This result indicates that the mouse genome, as
expected, is far from being saturated with mutations. More mutations
would certainly be discovered using more sophisticated phenotyping
protocols. Seven of the 11 new mutant alleles induced in our experi-
ment have been localized on the genetic map as a first step towards
positional cloning.
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Introduction
The publication of the nearly complete
sequence of the genome of several mamma-
lian species including man, mouse and rat
must be considered a major achievement in
modern biology. Comparisons of these se-
quences using specialized software have al-
lowed geneticists to gather a large amount of
new information concerning the structure
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and organization of mammalian genomes.
However, if the computerized analysis of
these sequences helps in the identification of
genes and other important genomic se-
quences, it does not reveal much concerning
their function(s) and this is why, as of today,
functional information is available for no
more than 30% of the mammalian genes.
The challenge for the next decade of genom-
ic research will certainly be to sort out and
identify from the rest of the sequence the few
percents (probably of the order of 5%) of the
mammalian DNA with a functional activity
and to assign a role to it. The only reliable
way to reach this goal is to specifically ad-
dress this question by experimentation. Later,
with an increasing knowledge of the struc-
ture/function relationships, algorithms may
be developed to expand more rapidly our
knowledge of the mammalian genome.
Experiments performed with this aim are
based on two strategies. The first one, termed
“reverse genetics”, consists of the produc-
tion of targeted alterations in the genome
leading to either the non-expression or mis-
expression of a gene known only by its
sequence. Such mutations are in general en-
gineered in vitro by homologous recombi-
nation in embryonic stem (ES) cells, and
once they have been induced, mutant geno-
types are bred and their phenotypes care-
fully and thoroughly scrutinized in the con-
text of the whole organism. Due to its nature,
this strategy is a “top-down” approach. With
the availability of ES cells this strategy has
become very popular in many laboratories
and several hundreds of transgenic mice have
now been potentially generated worldwide.
More recently, several transnational projects
have been approved by funding agencies for
the concerted and systematic production of
at least one null (knockout) mutation in each
and every gene of the mouse genome (1-3).
There is no doubt that such projects, when
completed, will dramatically increase our
knowledge of the function of genes.
The second strategy for gene annotation is
based on the observation of phenotypic varia-
tions in a given population followed by the
molecular identification of the underlying ge-
netic factor(s) after positional cloning. Since it
proceeds from phenotype to genotype, this
strategy is a “bottom-up” approach and is
often called “forward genetics”. Both strate-
gies have been widely used in model organ-
isms, in particular in the mouse, and both have
advantages and drawbacks. The production of
targeted mutations is a straightforward ap-
proach for the annotation of genes with rela-
tively few limitations. One can consider, for
example, that any DNA sequence whose func-
tion is unknown can be altered in vitro, at least
theoretically, and mouse embryos can be pro-
duced with the mutation in the homozygous
state to study the phenotypic effect resulting
from the genetic alteration. With some refine-
ments these engineered mutations can even be
made conditional and/or tissue specific. How-
ever, the production of targeted alterations in
the genome requires experience and rather
sophisticated skills and equipment. More im-
portantly, in many instances, it ends up with
inconclusive phenotypes. This is the case, for
example, when the inactivation of the targeted
gene leads to early embryonic death or, con-
versely, when it leads to a very subtle or
difficult to assess phenotype or even to no
phenotype at all. Finally, the very small genes,
and especially those with only one exon, are
difficult to inactivate for practical reasons.
The second strategy, the positional cloning
of mutations whose phenotype is obvious, is,
in general, a tedious enterprise that requires
the breeding of hundreds of mice to reduce the
genetic interval harboring the mutant locus to
a reasonable size, but it has the great advan-
tage that it is always informative and requires
only simple molecular techniques. In fact, one
should consider that both strategies are comple-
mentary rather than alternative, although with
the peculiarity that, while in vitro genetic engi-
neering is universally applicable, positional
cloning requires that mutations with a clear cut
phenotype be available.
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In this paper we report the conclusions of
an experiment we undertook to produce new
mouse mutations with the potent chemical
mutagen ethylnitrosourea (ENU). We de-
tected 11 new mutant alleles, 7 of which
have been localized on the mouse genetic
map as a first step towards positional clon-
ing. Three of these mutations are new alleles
at loci where at least 1 other mutant allele
already existed. Among the other 8, at least 5
seem to be original and occurred at loci
where no previous mutant allele had ever
been reported before.
Material and Methods
Animals
Mice of the inbred strains BALB/c,
C57BL/6 and NZB were obtained from the
breeding facilities of the Department of Im-
munology, Institute of Biomedical Sciences,
University of São Paulo (ICB-USP). During
the experiment, these mice were bred and
kept in micro-isolators inside rooms with
sanitary barriers. The temperature was main-
tained at 21 ± 2ºC, with 12-h light and dark
intervals. The mice were given commercial
food (Nuvital™ - Nuvilab, Curitiba, PR,
Brazil) and water ad libitum. Our experi-
mental project was approved by the Ethics
Committee of ICB-USP on September 14,
2000, with the registration number 29/2000.
ENU treatment
The BALB/c strain was chosen in our
protocol because, according to the literature,
it tolerates ENU treatment better than others
and has already been successfully used in
several mutagenesis experiments (for review,
see Refs. 4-7). Another advantage of this
strain is that its phenotypic characteristics
are relatively well known (http://www.jax.
org/phenome) and its genetic polymorphism
in terms of microsatellite (and now single
nucleotide polymorphisms) density has been
extensively assayed (http://www.mmdap.
org/snppanelres.html), facilitating the study
of genetic linkage for the induced mutations.
On the other hand, a major drawback of
using an albino strain is that, because of
epistasis, other coat color mutations cannot
be detected.
ENU (Sigma, St. Louis, MO, USA) was
dissolved in citrate phosphate buffer, pH 5.
Male mice aged 8 to 10 weeks received a
single intra-peritoneal injection of 200 or
250 mg/kg or multiple injections of 95 or
100 mg/kg at weekly intervals for 3 or 4
weeks. Treated mice were held in complete
isolation for 1 week until carcinogenic sub-
stances had been cleared. Waste and bed-
ding were detoxified by soaking in a concen-
trated bleach solution.
Breeding scheme
ENU treatment induces a sterile period of
up to 7 months. After recovering fertility, the
treated BALB/c males were mated with
BALB/c females, and the offspring (G1 gen-
eration) were scrutinized to detect variations
from the classical phenotype. To identify re-
cessive mutations, G1 males were mated with
normal BALB/c females and mated again with
4 of their (G2) female offspring. At least two
progenies of these G2 females were back-
crossed with their G1 father and were then
observed to reach the minimum number of 10
G3 offspring. In doing so, we optimized the
probability of detecting most of the ENU-
induced recessive mutations segregating in
the micro-pedigree by placing them in the
homozygous state (Figure 1) (8). Statistical
analysis indicates that, in these conditions, the
non-observation, just by chance, of a mutant
mouse in a cross where it is supposed to occur
is ≤0.1 (at the 5% risk level). For those pedi-
grees where a phenodeviant was observed,
either in G1 or G3, breeders from the main
colony were set aside for detailed analysis, but
in all cases the new mutation was kept in a
BALB/c co-isogenic status.
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Crosses for genetic mapping
Mapping genes identified only by a phe-
notype requires several crosses to be set in
which the phenotype in question segregates
with the largest possible amount of genetic
polymorphisms detectable at the DNA level
(8). Since all our mutations were, by defini-
tion, induced in a BALB/c background we
deliberately chose C57BL/6 or NZB strains
as partner strains to cross with for the pur-
pose of mapping. Choosing these two strains,
which are distantly related to BALB/c, opti-
mizes the distribution and density of genetic
polymorphisms of all kind across the ge-
nome (9).
Dominant mutations were located by
crossing the mutant mice observed in G1
(co-isogenic BALB/c) with mice of the part-
ner strain followed by a backcross with the
same partner strain (Figure 2A). For viable
and fertile recessive mutations, mice ho-
mozygous for the mutant allele were crossed
to the partner strain and then heterozygous
F1 were either intercrossed or backcrossed
with heterozygous BALB/c partners (Figure
2B1,B2). For homozygous inviable or infer-
tile recessive mutations, heterozygotes for
the mutant allele on the BALB/c background
were crossed with the partner strain and the
F1 progenies were crossed randomly. Only
the progenies (roughly 1/4) in which mutant
phenotypes were found segregating in F2
were retained for genotyping (Figure 2C). In
the backcross progeny, all mice were infor-
mative and each one represented one mei-
otic event in the computation for genetic
distances. In contrast, in F2, only the mice
with a mutant phenotype were considered
but each one of them was counted for two
meiotic events.
Detection of linkage and chromosomal
assignment
The localization of loci affected by a new
mutation was based on the detection of link-
Figure 1. Screening strategy used following ethylnitrosourea (ENU) mutagenesis in mice.
BALB/c (ENU-treated) males were mated with several BALB/c females and their progeny
(G1) were observed for dominant mutant phenotypes. G1 males were then mated with wild-
type BALB/c females to produce the generation G2. Mating of the G2 females to their G1
father produced the G3 progeny that were also screened for recessive phenotypes. *Four
G2 females were mated with their G1 father.
Mutant phenotype identification
Mutant phenotypes were identified by
careful examination of G1 and G3 offspring,
both for their behavior and integrity from
birth to weaning. Mice were checked peri-
odically and the accumulated information
was used to help the phenotypic description
of the potential mutant. A grid with several
parameters being checked was used during
the observation period, as shown in Table 1.
The observation of a deviant phenotype in
one pedigree was followed up to the adult
age and confirmed by the observation of
other mutant mice with similar phenotype in
the same pedigree, either in G2 (dominant
mutation) or in G3. Phenotypic character-
ization of each mutation, including histopa-
thology, morphology and behavior, was
achieved while genetic mapping was in
progress. For most mutations, highly de-
tailed phenotyping is now in progress and
the results will be published later.
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age disequilibrium after a complete genome
scan was achieved using at least 50 DNA
samples collected from the individual mu-
tant mice and a panel of 54 carefully selected
microsatellite markers (http://www.infor-
matics.jax.org) polymorphic between the two
strains involved in the crosses. These mark-
ers were evenly distributed throughout the
different chromosomes of the mouse genetic
map. Once linkage disequilibrium was found,
more markers on the same chromosome were
selected to confirm and refine the localiza-
tion. At this step of our experimental proto-
col we never attempted to perform high reso-
lution mapping as we plan to do in the future
for those of our mutations that are consid-
ered worthy of positional cloning.
Results
Efficiency of the ENU treatments
Four types of ENU treatments were used
in order to determine the optimal dose(s) and
protocol to use with BALB/c males under
our experimental conditions. We found that
all four treatments led to a sterile period
lasting 21 to 30 weeks (Table 2). We did not
find any obvious difference in terms of mor-
tality rate between the different doses of
ENU administered. Splitting the dose into
three shots of 95 or 100 mg/kg each admin-
istered at weekly intervals seems to be corre-
lated with a higher level of fertility (after the
sterile period) but does not reduce mortality
in a significant manner. Mutants were in-
duced in all cases as shown in Table 2.
Mutants collected
Nineteen phenodeviants were observed
in the 207 micro-pedigrees (G1 and G3)
analyzed, out of which 11 mutations could
be fixed as BALB/c co-isogenic strains. Table
3 describes the phenotypes observed and,
for some of these mutations, the chromoso-
mal locations.
Table 1. Phenotyping checklist of the mouse G1 and G2 population.
Pedigree No. __________ Birth date __ /__ / __ Observation date __ /__ / __
1) Size Normal Small Large Runted
2) Sense organs
Eye size Normal Small Large
External ear size Normal Small Large Snout shape
External ear position Normal Low-set
3) Skin and fur
Abnormally white
Curly coat/whiskers
Greasy/rough coat
Thin/balding coat
4) Skeleton
Jaws Normal Small size
Head Normal Small size
Spine Normal Scoliosis
Tail Normal Small Bent tail
Toes Normal Fused toes Polydactyly Syndactyly
5) Behavior
Activity Normal Diminished Increased
Tremors
Circling
Seizures
Abnormal head movement
Abnormal gait
Abnormal behavior when held by tail
6) General
Hydrocephaly
Spina bifida
Edema
Ascites
Blebs
Bruising
Observations:
_________________________________________________________________________________________________________________________________________________________________________________
_________________________________________________________________________________________
__________________________________________________________________________________________________________________________________________________________________________________
Only 1 dominant mutation was recog-
nized while all other were recessive. If we
consider the number of phenodeviants ob-
served in G1 it is likely that several other
dominant mutations were lost mainly due to
poor viability or infertility. The 10 recessive
mutations, affecting skin or fur, gait, devel-
opment, or behavior are listed in Table 3.
The first mutation mapped, mergulhador
(“diver”; symbol - mlh), severely affects the
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tossing. The locus for mlh is on chromosome
5 (Chr 5) and was identified as an allele of
the mutation tilted (tlt) that affects otoconial
morphogenesis without causing collateral
deafness. Tilted and mergulhador are then
two alleles at the Otopetrin 1 (Otop1) locus.
The gene encodes a multi-transmembrane
domain protein that is expressed in the macula
of the developing otocyst. Both mutants carry
single point mutations leading to non-con-
servative amino acid substitutions that affect
two putative transmembrane (TM) domains
(Otop1tlt is an Ala151!Glu substitution in
TM3; Otop1mlh is a Leu408!Gln substitution
in TM8). The existence of two mutant alleles
at the Otop1 locus has facilitated the posi-
tional cloning of the tilted locus (10).
The mutation careca (“bald”; symbol -
carc) induces hair abnormalities from the
first coat. Mice are viable and fertile but
display pronounced alteration of fur, although
they have normal whiskers. The fur is sparse
during the entire life of the mutant mice
(Figure 3B), especially around the eyes and
on the limbs and belly. Between 45 and 60
days of age, most mice lose all of their fur
and become virtually naked. Histological
analysis of adult skin showed an increase of
skin thickness due to a large number of
follicles in anagen, which is the active growth
phase when the hair fiber is produced. At the
same age hair follicles of control BALB/c
mice were mostly in telogen, known as a
resting stage. Careca has been mapped to
Chr 7, between D7Mit96 (50 cM) and
D7Mit174 (69 cM). In this interval of mouse
Chr 7, no other mutation with a similar phe-
notype has been reported previously, lead-
ing us to guess that this mutation might
affect a previously unknown locus.
The mutation Sacudidor de cabeça (“head
shaker”; symbol - Sacc) is a dominant muta-
tion. Mice affected by this mutation (Sacc/+)
continuously shake their head but do not run
in circles. The intensity of head tossing and
shaking increases when the mouse is dis-
turbed. Mice are not deaf and when stimulat-
Figure 2. Breeding schemes for the mapping of the ENU-induced mutations. A, Backcross
for dominant mutations; B1, intercross and B2, backcross for viable and fertile recessive
mutations; C, intercross for inviable and infertile mutations. In the backcross progeny, all
mice are informative and each one of them represents one meiotic event in the computation
for genetic distances. In contrast, in F2, only the mice with a mutant phenotype are
considered but each one of them is counted as two meiotic events. F1 = first filial genera-
tion.
swimming abilities of affected mice when
put in a water tank (Figure 3A1 and 3A2).
Under normal conditions, mlh/mlh mice ex-
hibit head tilting but show no other behav-
ioral abnormalities such as circling or head
BALB/c (Mut/+) X C57BL/6 or NZB
Mut/+ F1 X C57BL/6 or NZB
A
+/+ Mut /+
BALB/c (mut/mut ) X C57BL/6 or NZB BALB/c (mut/mut ) X C57BL/6 or NZB
+/mut F1 X BALB/c (mut/mut)
BALB/c (+/mut ) X C57BL/6 or NZB
+/mut X +/mut F1
+/mut mut/mut Backcross
Backcross
mut/mut +/mut F2Intercross +/+
+mut  X +/+ +/+ X +/mut +/+ X +/+ +/mut  X +/mut F1
Intercross F2 +/+ mut /mut +/mut
B1 B2
C
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Table 2. Mortality, ethylnitrosourea (ENU)-induced sterile period, fertility, number of pedigrees established,
and confirmed mutations scored in mice.
ENU dose Males Mortality Sterile period Fertility Established Mutants obtained
(N) (%) (weeks) (%) pedigrees
250 mg/kg 35 42.9 30 28.6 49 mergulhador, rodador, Sacudidor
de cabeça
200 mg/kg 34 26.5 22 5.9 16 careca
3 x 100 mg/kg 30 13.3 30 40.0 70 equilíbrio, nervoso, cruza pernas,
sem pelo, bate palmas
3 x 95 mg/kg 10 40.0 21 50.0 72 anêmico, fraqueza
Figure 3. Ethylnitrosourea (ENU)-
induced mutant mice. A, an mlh/
mlh mouse (A1) circles and is
submerged in water, whereas a
wild-type mouse (A2) swims. B,
a carc/carc mouse presents
sparse hair throughout its life-
time. C, an eqlb/eqlb mouse
twists upwards (C1) while a wild-
type mouse shows a normal po-
sition when held by its tail (C2).
D, a nudesepe/nudesepe mouse
presents no hair throughout its
life. E, a frqz/frqz mouse loses
movement coordination (45 days
old). F, a bapa/bapa mouse, and
G, a crup/crup mouse show ab-
normal movement of their hind
legs when held by the tail, while
a wild-type mouse (H) does not
cross its legs.
Table 3. Mode of inheritance, major phenotype, chromosome location, and abbreviations of ethylnitrosourea-
induced mutations in mice.
Mutation Mode of inheritance Major phenotype Chromosome location Abbreviation
anêmico Recessive Anemia Not yet mapped anem
bate palmas Recessive Clapping with hind Not yet mapped bapa
limbs when held by tail
careca Recessive Fur development Chr. 7 carc
cruza as pernas Recessive Crossing limbs when Not yet mapped crup
held by their tail
equilíbrio Recessive Tilted head Chr. 17 eqlb
fraqueza Recessive Progressive loss of Chr. 1 frqz
motor coordination
mergulhador Recessive Tilted head Chr. 5 Otop1mlh
nervoso Recessive Anxiety, abnormally Not yet mapped nerv
nervous behavior
rodador Recessive Circling behavior Chr. 10 roda
Sacudidor de cabeça Dominant Head tossing Chr. 15 Sacc
sem pelo Recessive Fur deficiency Chr. 11 Foxnsepe
A1 A2 B
EC2 D
F G H
C1
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ed by an acute sound burst (the so-called
click box used for generating the Preyer
reflex) their head shaking intensifies. This
movement stops only when the mice are
asleep. This mutation was located on Chr 15,
between D15Mit100 (21 cM) and D15Mit242
(55 cM) and here, again, no other mutations
with a similar phenotype have been reported.
The recessive mutation rodador (“cir-
cler”; symbol - roda) makes the mice con-
tinuously walk in circles while moving their
head up and down (nodding). Here, again,
stressing the mutant mice worsens the phe-
notype. Homozygous roda/roda mice are
deaf. The roda mutation has been located on
Chr 10 between D10Mit170 (29 cM) and
D10Mit95 (51 cM), very close to the waltzer
locus (Cadherin 23 or Otocadherin) where
several other mutant alleles (actually 18)
have already been reported. Given the phe-
notype and the linkage data we suspected
roda to be a new allele at the waltzer locus
and did not pursue the investigation.
Another recessive mutation discovered
in our program was designated equilíbrio
(“equilibrium”; symbol - eqlb) because of
the abnormal motor coordination it causes.
Affected mice always keep their head tilted
downward (Figure 3C) and cannot stay on a
rota-rod apparatus, suggesting that their cer-
ebellum development is impaired. The
equilíbrio mutant has been located on Chr
17, proximal to D17Mit113 (6 cM). No simi-
lar mutation has been reported in this region.
Mice affected by the mutation sem pelo
(“furless”; symbol - sepe) never grow any
fur throughout their lives (Figure 3D). In
such mice, the thymus is absent and a ge-
netic allelism test with BALB/c-nude con-
firmed that sepe is a new allele at the nude
locus (Foxn1sepe).
Mice affected by the recessive mutation
fraqueza (“weakness”; symbol - frqz) pro-
gressively lose movement coordination and
die between 4 and 6 weeks of age (Figure
3E). Their lifespan can be slightly extended
by enriching the cage environment and mak-
ing water and food available inside the cage
since the mice can no longer stand up to get
them. The fraqueza mutant has been re-
cently located on Chr 1 between D1Mit3 (11
cM) and D1Mit504 (81 cM). No spontane-
ous mutations with a similar phenotype have
been reported in this genetic interval but
several knockout alleles (in particular at the
Erbb2, Ngf and Otx1 loci) exhibit a similar
wasting neuromuscular syndrome. Allelism
tests have not yet been done.
The recessive mutation anêmico (“ane-
mic”; symbol - anem) is characterized by a
yellowish color at birth, easily observed in a
BALB/c progeny with normal and mutant
littermates. Adults exhibit extremely white
ears and tail. Fertility is reduced in both
males and females. Preliminary phenotype
characterization showed a reduction in red
blood cell number and an increase in reticu-
locyte and leukocyte number, two symp-
toms specific for anemia. This mutation has
not yet been assigned to a specific chromo-
some.
Mice affected by the recessive mutation
bate palmas (“applauding”; symbol - bapa)
and cruza pernas (“leg crossing”; symbol -
crup) both exhibit abnormal movement of
the hind limbs when held by their tail (Figure
3F,G). These reactions are suggestive of
abnormal motor coordination. Phenotype
characterization and mapping for these two
mutations is in progress.
The recessive mutation nervoso (“ner-
vous”; symbol - nerv) is characterized by
obvious hyperactivity. Mutant mice move
very rapidly when observed in their cages
and shake vigorously when held by the tail.
Seizures have also been observed in some
mice. Phenotypic characterization and map-
ping are in progress.
Discussion
ENU is a powerful mutagen that can
induce a wide variety of point mutations in
the mouse genome (5,6,11). These point
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mutations are of various kinds, including
nonsense and missense mutations and, un-
like those resulting from genetic engineer-
ing in ES cells, they do not systematically
nullify gene activity. Many cases have been
reported where a missense mutation in a
gene resulted in a less severe (or different)
phenotype than would be produced by com-
plete inactivation, and for this reason, at
least, ENU mutagenesis appears to be an
excellent strategy for gene annotation. An-
other advantage of ENU mutagenesis is that
all genes in the genome are potential targets
with the frequency of a hit in any one of them
being (probably) proportional to the size of
the gene in question. In addition, once a first
mutant allele has been induced at a given
locus, ENU mutagenesis can be used to effi-
ciently generate a series of other mutant
alleles at the same locus, with hits in various
domains of the transcribed molecule (see
Ref. 6, for details). On the contrary, gene
trapping or gene targeting is possible only if
the targeted genes are transcribed in the ES
cells while grown in vitro, and yield mostly
nonfunctional alleles. In fact, the only major
drawback of ENU mutagenesis for gene an-
notation is that it requires comprehensive
phenotyping followed by the tedious pro-
cess of positional cloning.
The efficiency of the mutagenic treat-
ment of male mice depends upon the dose
and rate of administration of the chemical.
With fractionation of the treatment into doses
of 100 mg/kg, Hitotsumachi and colleagues
(7) obtained a higher mutation rate than after
administration of a single dose. In our ex-
periment fractionation did not seem to have
any obvious effect. However, splitting the
ENU dose into three injections of 100 mg/kg
each resulted in increased fertility.
In our experiment we identified 11 muta-
tions, 3 of which appeared to be new alleles
at loci where at least another mutant allele
had already been identified (Otop1mlh,
Foxn1sepe and probably rodador) and 4 are
probably new and unique mutations, i.e., at
loci where mutant alleles never occurred
previously (carc, eqlb, frqz, and Sacc). The
status for the last 4 is not yet known in
enough detail to decide to which category
they belong. The identification of new muta-
tions is in agreement with previous observa-
tions made in other projects operating on a
larger scale (12,13) and indicates that the
mouse genome is still far from being satu-
rated with mutations. When this is the case
most of the induced mutations will fall in the
first category, merely implementing the al-
lelic series at a given locus.
At this point, it is important to emphasize
that the only strategy we used to detect mu-
tant genotypes was the observation of gross
morphology, of the skin and fur, of the gait
and behavior among the G1 and G3 off-
spring population from birth to weaning.
This obviously represents a relatively super-
ficial phenotyping excluding, for example,
all the pathologies with a late onset. In the
same way, recessive mutations resulting in
stillbirths probably remained unnoticed and,
since the mice we used were all albino and
kept in highly protected environments, all
mutations with an effect on coat color or
resulting in immunodeficiency were also not
detected. With a more comprehensive phe-
notyping we certainly would have detected
more phenodeviants. More sophisticated
methods of phenotyping such as magnetic
resonance and radiology are now being de-
veloped to complement and speed up the
characterization of the mutants (14).
Another important point was the choice
of the BALB/c strain in our experiment. On
this background we could easily recognize
the ENU-induced nervoso mutation; how-
ever, when we crossed heterozygous +/nerv
mice with normal (+/+) mice of the C57BL/6
strain for the purpose of mapping, we had
tremendous difficulties in sorting out mutant
mice from their normal counterparts in the
same litter. We had the feeling that the muta-
tion got lost in the cross while it was prob-
ably a mere background effect. In fact, we
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found a dramatic reduction in the proportion
of nervoso (nerv/nerv) mice in the F2, lead-
ing us to believe that some genes with a
strong modifying effect were segregating in
this specific cross, reducing the phenotypic
expression of the mutant allele in the BALB/c
background. Such alterations of the pheno-
typic expression are commonly observed in
mammalian genetics, but to explain this phe-
nomenon in genetic terms is, in most in-
stances, extremely difficult. In this respect,
the mouse appears to be most appropriate
because, in this species, it should be possible
not only to identify the modifying genes by
their effect on the phenotype, but also to
clone them. Analyzing modifiers of the phe-
notypic expression will certainly be a major
issue in tomorrow’s medical genetics.
One of the drawbacks of using chemical
mutagenesis is that, having identified an aber-
rant phenotype, it still requires considerable
effort to identify the underlying genetic defect
(15). On the other hand, chemical mutagen-
esis provides medical geneticists with a lot of
new animal models that can be used to repli-
cate some human diseases. Here again, the
mouse mutation nervoso is a good example of
a neurological syndrome that is amenable to
chemical treatment and mutant mice can be
used to assess the activity of new molecules
even if they are not (yet) known at the molec-
ular level. Animal models of epilepsy and of
Parkinson’s disease are badly needed and our
nervoso mice could be of interest in this con-
text.
The next steps of our project will be to
map the most interesting of these mutations
at high resolution based on their phenotype
using additional crosses and markers. The
information that will be gathered from the
functional studies should help understand
the ways genes are involved in the determin-
ism of biological functions.
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